NewsVoir http://newsvoir.com <![CDATA[Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=35704 <![CDATA[Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=35343 <![CDATA[Morepen Bags Rs. 825 Crore Global Deal]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=34737 <![CDATA[Morepen Labs Eyeing Multi-billion Dollar Global Market for New API Molecules going Off-patent in next 5-6 Years]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=15711 <![CDATA[Morepen Labs' Performance Catches Pace in Q2'FY2020-21 with a Six-fold Rise in its Net Profit Led by Strong API Business]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=15007 <![CDATA[Morepen Labs' Net Profit Rises by 153 Per cent Led by Strong API Business in Q1'FY 2020-21]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=14496 <![CDATA[Morepen Labs Clocks Double Digit Growth in its Sales and Net Profit in FY 2019-20]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=14058 <![CDATA[Morepen Laboratories Gets ISO-13485 Certification for its Medical Devices Manufacturing Facility at Baddi (HP)]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=13817 <![CDATA[Morepen Labs takes up the COVID Battle with its Infrared Thermometers, Hand Sanitizers and Face Masks in Indian Market]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=13779 <![CDATA[Morepen Labs' Net Profit Rises by 21% in Q3' FY 2019-20 Led by a Stable Performance in All Business Segments]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=13442 <![CDATA[Morepen Labs Reports 24% Rise in its Net Sales and 34% Rise in Net Profit in First Half of FY 2019-20 Led by a Significant Jump in its Bulk Drugs and Home Diagnostics Businesses]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=12833 <![CDATA[Morepen Labs Adds three New Drugs - Rivaroxaban, Vildagliptin and UDCA to its API Portfolio]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=12638 <![CDATA[Morepen Labs Catches Pharma Sector Uptrend in Q1 FY 2019-20. Company's Net Profit Rises by a Whopping 256 Percent Led by a Significant Jump in its APIs Exports]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=12286 <![CDATA[Morepen Labs Profit Rises by 125 Percent in Q4 FY 2018-19 Led by Good Growth in All Business Segments]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=11786 <![CDATA[Morepen Labs begins FY 2018-19 with a Sound Performance in the First Quarter]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=10534 <![CDATA[Twin USFDA Approvals for Morepen Labs' Bulk Drugs (API) Facilities]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=10466 <![CDATA[Morepen Labs Reports Growth-filled Fourth Quarter to Close FY 2017-18 with a 25 Per cent Rise in its Net Profit]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=10191 <![CDATA[Morepen Labs Boards the Growth Ladder with the Peer Group in the Healthcare and Pharmaceutical Sector]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=9707 <![CDATA[Morepen Gets US FDA Clearance for its Bulk Drug Montelukast Sodium]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=9635 <![CDATA[Morepen Labs Reports 24 Per cent Jump in its Q2 Net Profit Backed by Lower Interest Cost and Improved Home Diagnostics' Sales]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=9460 <![CDATA[Morepen Labs Ties-up with Vésale Pharma of Belgium ]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=9446 <![CDATA[Higher Revenue from Exports, Bulk Drugs and Home-Diagnostic Businesses Fuel Morepen Lab's Sales and Profitability Growth in Q4 FY 2016-17]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=8615 <![CDATA[Morepen Labs Reports yet another Growth-Filled Quarter]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=8224 <![CDATA[Morepen Labs Strengthens its Position in Bulk Drugs Market for Montelukast and Rosuvastatin]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=7250 <![CDATA[Morepen Laboratories Reports 203% Rise in Net Profit and 15% Rise in Total Income in First Nine Months of Current Fiscal]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=6120